Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor gamma locus (TRG) is a complex genomic region located on chromosome 7 (7q14) that encodes the gamma chain of the T-cell receptor (TCR) complex [1, 2]. This locus is essential for the development of gamma-delta (γδ) T cells, a distinct subset of T lymphocytes that participate in both innate and adaptive immune responses [3]. During T-cell maturation in the thymus, the TRG locus undergoes somatic V(D)J recombination to create a diverse repertoire of TCR gamma chains, which pair with delta chains to recognize non-peptide antigens in an MHC-independent manner [2, 5]. Clinically, the TRG locus is a vital biomarker for diagnosing T-cell malignancies, as clonal rearrangements can be detected via PCR to distinguish malignant proliferations from reactive ones [4]. In the field of immunotherapy, the protein products of this locus are targeted by novel agents, including bispecific T-cell engagers and adoptive cell therapies, aimed at leveraging γδ T cells for the treatment of various cancers [5].
Activation and recruitment of gamma-delta T-cells for targeted cytotoxicity against tumor cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor gamma locus (TRG) (TRG).